Loading... Please wait...

Our Newsletter

SYN115 | Adenosine A(2a) receptor antagonist

  • SYN115.jpg
  • SYN115, 400x400px, png
Catalog #:

Product Description

SYN115 (Tozadenant) is a orally-available, benzothiazole-based, antagonist of the Adenosine A2A receptor for the treatment of Parkinson's disease and other CNS-related conditions. SYN115 is being pursued as a monotherapy as well as in combination with L-dopamine and is being studied for its potential neuroprotective effects. [1]

Animal studies with SYN115 support beliefs that A2A antagonists reduce Parkinson's symptoms by reducing the inhibitory output of the basal ganglia indirect pathway. Using Cerebral Blood Flow (CBF) as a pharmacodynamic parameter, studies have shown that SYN115 induces a significant decrease in thalamic CBF, consistent with the deactivation of the indirect pathway. [2]

Technical information:

Chemical Formula:   C19H26N4O4S
CAS #:   870070-55-6
Molecular Weight:   406.5
Purity:   > 98%
Appearance:   White
Chemical Name:   4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl]-4-methyl-1-piperidinecarboxamide
Solubility:   Up to 50 mM in DMSO
Synonyms:   SYN115, SYN-115

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Biotie Therapies website (2013-04-24)
2. Black et al., Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease. Black et al., J. Neurosci. 2010, 30(48), 16284-16292. Pubmed ID: 21123574

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Find Similar Products by Category

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the SYN115 | Adenosine A(2a) receptor antagonist to your wish list.

You Recently Viewed...